|
(Updated, 1:18 p.m.)
Biomedical Structures LLC, the developer of biomedical textiles for medical devices, has merged with Modified Polymer Components, a Sunnyvale, Calif.-based company specializing in the design, rapid prototyping and manufacture of polymer components for medical device original equipment manufacturers.
more
By PBN Staff
|
|
Forbes Magazine has named Swipley Inc. one of “America’s Most Promising Companies.” Swipely, which was founded in 2009, is the first Rhode Island company to make the list.
more
By PBN Staff
|
|
Procurement deals between Global 2,000 companies and their suppliers can be worth hundreds of millions of dollars and are increasingly fulfilled through software from firms such as Oracle and SAP.
more
By Patrick Anderson |
|
Care New England announced today that is partnering with Epic as its new ambulatory clinical information technology partner, moving all of the hospital network’s employed physicians and practices to a single electronic medical record platform.
more
By Richard Asinof |
|
With more than 618 million active, daily Facebook users, 500 million registered Twitter handles and more than 200 million LinkedIn profiles, it’s easy to see why companies from boutiques to big-box stores have realized the importance of a strong online presence in today’s society.
more
By Emily Greenhalgh |
|
In late January, GTECH Corp.’s Rome-based parent company Lottomatica Group SpA announced its decision to re-brand to GTECH SpA, pending shareholder approval. Along with the name change, the group also announced plans to reorganize its business structure from units focusing on their respective products to focusing on geographic regions: the Americas, Italy and international.
more
By Emily Greenhalgh |
|
Tech Collective, Rhode Island’s bioscience and IT industry association, has announced the six winners of its inaugural Rhode Island Bioscience Awards.
more
By PBN Staff
|
|
If a company has customers, then it also has data about them. For some businesses, the uncertainty comes in how to harness that data and leverage it to their benefit.
more
By Lindsay Lorenz |
|
Amgen Inc., one of the world’s biggest biotechnology companies, will spend as much as $180.5 million for the right to develop cancer drugs using nanotechnology from closely held Bind Biosciences.
more
By Elizabeth Lopatto |
|
Amgen Inc., one of the world’s largest biotechnology companies, has agreed to buy genetic-testing company deCode Genetics Inc. for $415 million, Amgen announced Monday.
more
By PBN Staff
|
